Sexually Transmitted Disease (STD) Testing Markets

Description:

Sexually transmitted diseases (STDs) present a significant public health challenge, with approximately 550 million new cases worldwide each year, including over 35 million in the US alone. Kalorama Information’s latest report, Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics), offers an in-depth analysis of the global market for STD testing services and diagnostics from 2018 to 2023.

Report Highlights:

• Comprehensive Market Overview:
  • Analysis of the global market for STD diagnostics, including:
    • Chlamydia
    • Gonorrhea
    • Syphilis
    • Human Papillomavirus (HPV)
    • Human Immunodeficiency Viruses (HIV)
    • Herpes Simplex Virus (HSV)
    • Trichomonas Vaginalis (TV)
• Geographic Analysis:
  • Detailed examination of the STD diagnostics market by region:
    • World Market for STD Diagnostics, 2018-2023 ($ billions)
    • Regional Markets:
      • North America (US, Canada, Mexico)
      • Europe-Africa (UK, Spain, France, Italy, Germany, Africa)
      • Asia-Pacific (Japan, China, India, Australia)
      • South America (Argentina, Brazil, Chile)
      • Rest of World (ROW)
• Market Analysis by Disease and Region:
  • Insights into the market for STD diagnostics by disease and region, covering trends and growth opportunities.
• Market Analysis by Testing Location and Laboratory Type:
  • Breakdown of the market by testing location, including laboratory-based and point-of-care (POC) testing.
  • Analysis by laboratory type (hospital labs, independent labs, physician office labs).
• Market Analysis by Testing Device:
  • Examination of various diagnostic methods, including molecular platforms, lateral flow assays, flow cytometry, and ELISA diagnostics.
• Key Market Trends and Developments:
  • Discussion of important market trends, such as antibiotic resistance, non-reportable STDs, emerging STDs, and advancements in STD testing technologies.

Data Points Included:

• Global and regional market sizes for STD diagnostics from 2018 to 2023
• Market segmentation by disease type and testing location
• Analysis of laboratory types and testing devices

For further details and to purchase directly, please contact us.

Sample Report: A sample is available as a PDF upon request.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table: Global Sexually Transmitted Disease (STD) IVD Test Kit and Reagent Market, by Test Type & Condition, 2018-2026 (in millions $)

Item – Year	2018	2019	2020	2021	2022	2023	2024	2025	2026	CAGR
By Type of Test
Immunoassay	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Molecular	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Other	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
By Condition
Chlamydia	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
HPV	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Gonorrhea	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Herpes HSV-2	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Syphilis	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Other	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Global STD IVD Market	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
HIV	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%

Source: Kalorama Information